======= GCN1L1 ======= == Gene Information == * **Official Symbol**: GCN1 * **Official Name**: GCN1 activator of EIF2AK4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10985|10985]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92616|Q92616]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GCN1L1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GCN1L1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605614|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |DUF3554| |protein kinase regulator activity| |cellular response to leucine starvation| |translation factor activity, RNA binding| |positive regulation of transcription from RNA polymerase II promoter in response to stress| |polysome| |cellular response to amino acid starvation| |ribosome| |response to amino acid starvation| |ribosome binding| |regulation of transcription from RNA polymerase II promoter in response to stress| |regulation of DNA-templated transcription in response to stress| |cellular response to starvation| |response to starvation| |cellular response to nutrient levels| |cellular response to extracellular stimulus| |cadherin binding| |cellular response to external stimulus| |regulation of translation| |translation| |regulation of cellular amide metabolic process| |peptide biosynthetic process| |protein kinase binding| |response to nutrient levels| |posttranscriptional regulation of gene expression| |amide biosynthetic process| |peptide metabolic process| |response to extracellular stimulus| |positive regulation of kinase activity| |positive regulation of transferase activity| |cellular amide metabolic process| |regulation of protein kinase activity| |regulation of kinase activity| |regulation of transferase activity| |positive regulation of phosphorylation| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of transcription by RNA polymerase II| |RNA binding| |organonitrogen compound biosynthetic process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |positive regulation of transcription, DNA-templated| |regulation of phosphorylation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular response to stress| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp447|Amiloride 100μM R08 exp447]]|-2.05| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.89| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.87| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.7| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.71| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|1.71| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.87| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|1.87| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|2.06| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.25| |[[:results:exp210|LB-100 2μM R05 exp210]]|2.32| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|2.35| |[[:results:exp180|Dynasore 10μM R04 exp180]]|2.41| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.45| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|2.45| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.51| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|2.76| |[[:results:exp512|Olaparib 4μM R08 exp512]]|3.48| |[[:results:exp264|Arsenate 40μM R06 exp264]]|3.5| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|3.52| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|3.58| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|4.27| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|4.28| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|6.17| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|7.43| ^Gene^Correlation^ |[[:human genes:e:eif2ak4|EIF2AK4]]|0.593| |[[:human genes:s:serbp1|SERBP1]]|0.412| Global Fraction of Cell Lines Where Essential: 100/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|5/28| |blood|3/28| |bone|2/26| |breast|5/33| |central nervous system|6/56| |cervix|3/4| |colorectal|6/17| |esophagus|1/13| |fibroblast|0/1| |gastric|1/16| |kidney|2/21| |liver|6/20| |lung|3/75| |lymphocyte|2/16| |ovary|1/26| |pancreas|3/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|2/24| |soft tissue|2/9| |thyroid|0/2| |upper aerodigestive|6/22| |urinary tract|4/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2418 * **Expression level (log2 read counts)**: 8.73 {{:chemogenomics:nalm6 dist.png?nolink |}}